Abstract:Dynamic contrast-enhanced MR imaging (DCE-MRI) can assess the integrity of the blood brain barrier (BBB) and has been used in GBM patients to determine glioma grade, predict prognosis, evaluate treatment response, and differentiate treatment-induced effect from recurrence. The volume transfer constant K trans is the most frequently used metric in tumor assessment. Based on previous studies that a higher WHO grade of brain tumor was associated with greater impairments of immunity and that K trans value was associated with the pathological grading, the relationship between differential composition of immune cells in GBM tissue and dynamic changes in K trans mapping was anticipated in this study. The present study utilized an orthotopic allograft model of GBM in which mouse GL26 cells are implanted into Ccr2 RFP/wt Cx3cr1 GFP/wt mice on a C57 background. The brain tumors exhibited heterogenous K trans values with the coefficients of variation (CV) above 75%, or relatively homogeneous K trans maps with CV values below 50%. The K trans values of homogeneous tumors ranged between 0.02/min–0.32/min with a median value of 0.10/min. The immune cell composition defined by quantitative immunohistochemistry and cell sorting was compared between the tumors with K trans values above 0.10/min (higher K trans ) or below 0.10/min (lower K trans ). Histological analysis showed that tumors with higher K trans values exhibited greater numbers of CCR2 pos cells (257.60 ± 16.42/mm 2 vs 203.23 ± 12.20/mm 2 , p = 0.04) and an increased ratio of CCR2 pos cells to CX3CR1 pos cells (1.20 ± 0.02 vs 0.38 ± 0.04, p = 0.001), the numbers of CX3CR1 pos cells did not differ significantly based on K trans values (219.70 ± 16.20/mm 2 vs 250.38 ± 21.20/mm 2 , p = 0.19). Flowcytometry analysis showed that tumors with higher K trans values (above 0.1/min) were associated with greater numbers of both overall monocytes (54.93 ± 6.81% vs 29.75 ± 3.54%, p = 0.01) and inflammatory monocytes (72.38 ± 1.49% vs 59.52 ± 2.44%, p = 0.001). In contrast, tumors with lower K trans values (below 0.1/min) exhibited greater numbers of patrolling monocytes (75.65 ± 4.14% vs 63 ± 6.94%, p = 0.05). In the tumors with lower K trans values, all three types of tumor associated cells, including patrolling monocytes, inflammatory monocytes, and microglia cells possessed a higher proportion of cells at pro-inflammatory status (41.77 ± 6.13% vs 25.06 ± 6.72%, p = 0.05; 27.50 ± 2.11% vs 20.62 ± 1.87%, p = 0.03; and 55.80 ± 9.88% vs 31.12 ± 7.31%, p = 0.05), inflammatory monocytes showed fewer anti-inflammatory cells (1.25 ± 0.62% vs 3.16 ± 3.56%, p = 0.04). Taken together, differences in K trans values were associated with differential immune cell phenotypes and polarizations. K trans mapping may therefore represent a novel approach for defining the immune status of GBM.

Dynamic enhanced MR scanning with volume transfer coefficient (Ktrans)in the evaluation of histopathologic grading of cere-bral glioma

Using Dynamic Contrast-Enhanced MRI to Predict the Histopathologic Grade of Cerebral Gliomas

Evaluation of volume transfer coefficient (Ktrans)in differentiating brain metastasis from high-grade gliomas

Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas.

Quantitative Evaluation of Ki-67 Labeling Index in Glioma with Transfer Constant Derived from Dynamic Contrast-Enhanced MRI

Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging

Assessing the Microvascular Permeability of Brain Glioma by DCE-MRI

Quantitative Analysis of Neovascular Permeability in Glioma by Dynamic Contrast-Enhanced MR Imaging

Differentiation between cerebral metastases , meningiomas , and primary gliomas by dynamic contrast-enhanced MRI

Quantitative Analysis of Permeability for Glioma Grading Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Influence of Different Contrast Agents on Dynamic Contrast-Enhanced MRI Ktrans in Cerebral Metastases: Comparison between 1.0 M Gadobutrol and 0.5M Gadopentetate Dimeglumine

The Value of Dynamic Contrast-Enhanced MRI Parameters of Extended Tofts and Exchange Model in the Differential Diagnosis of Cellular Uterine Leiomyoma

Microvascular Permeability of Brain Astrocytoma with Contrast-Enhanced Magnetic Resonance Imaging: Correlation Analysis with Histopathologic Grade.

Glioma Grading Capability: Comparisons among Parameters from Dynamic Contrast-Enhanced MRI and ADC Value on DWI

The Value of Diffusion-weighted and Perfusion MR Imaging in Evaluating the Histopathologic Grade of Cerebral Gliomas

Quantitative measurement of blood-brain barrier permeability with DSC-MRI and its primary application in diagnosis of gliomas

Correlation Between the Quantitative Parameter Ktrans Value of Dynamic Contrastenhanced MRI and Gleason Score in Prostate Cancer

Noninvasively Evaluating the Grading of Glioma by Multiparametric Magnetic Resonance Imaging

A quantitative study of grade of gliomas by applying dynamic contrast-enhanced MR imaging technique

Low-grade and Anaplastic Oligodendrogliomas: Differences in Tumour Microvascular Permeability Evaluated with Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Immune cell identity behind the K trans mapping of mouse glioblastoma